Patent application 13844138 (US), filed 2013-03-15
Publication number: US20140065110A1
Title: GENETICALLY MODIFIED MSC AND THERAPEUTIC METHODS
CPC codes: A61K  48/005
C12N  15/86
C12N2740/15043
Office action: rejection, dated 2015-10-15
Rejection reasons: anticipation_102
obviousness_103
indefiniteness_112
Prior art cited: ref_id: Chen European J. Clin. Investigation, 2005, Vol. 35, pg 677-686
ref_type: patent
severity: novelty_destroying
ref_id: 20030232431
ref_type: patent
severity: novelty_destroying
ref_id: 20030139333
ref_type: patent
severity: novelty_destroying
ref_id: Dai Frontiers in Biosci. 2007, Vol. 12, pg 4280-4287
ref_type: patent
severity: novelty_destroying
ref_id: 20040033949
ref_type: patent
severity: novelty_destroying
ref_id: 6387369
ref_type: patent
severity: novelty_destroying
ref_id: 20060275338
ref_type: patent
severity: novelty_destroying
ref_id: 20090131866
ref_type: patent
severity: novelty_destroying
ref_id: 20040048375
ref_type: patent
severity: novelty_destroying
ref_id: Chen European J. Clin. Investigation, 2005, Vol. 35, pg 677-686
ref_type: patent
severity: novelty_destroying
ref_id: 20030175410
ref_type: patent
severity: novelty_destroying
ref_id: 20070142282
ref_type: patent
severity: novelty_destroying
ref_id: 20100254900
ref_type: patent
severity: novelty_destroying
ref_id: 20030103951
ref_type: patent
severity: novelty_destroying
ref_id: Tiberghien Blood, 2001, Vol. 97, No. 1, pg 63-72
ref_type: patent
severity: novelty_destroying
ref_id: 20100267812
ref_type: patent
severity: novelty_destroying
Final disposition: pending (2015-10-15)